Two Apple Medical Trials Shed Light On How Healthkit Will Work

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

(Reuters) - Two prominent U.S. hospitals are preparing to launch trials with diabetics and chronic disease patients using Apple Inc’s (AAPL.O) HealthKit, offering a glimpse of how the iPhone maker’s ambitious take on healthcare will work in practice.

HealthKit, which is still under development, is the center of a new healthcare system by Apple. Regulated medical devices, such as glucose monitors with accompanying iPhone apps, can send information to HealthKit. With a patient’s consent, Apple’s service gathers data from various health apps so that it can be viewed by doctors in one place.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC